Bill Text: CA AB34 | 2015-2016 | Regular Session | Amended
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Medical cannabis.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Failed) 2016-02-01 - From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. [AB34 Detail]
Download: California-2015-AB34-Amended.html
Bill Title: Medical cannabis.
Spectrum: Partisan Bill (Democrat 3-0)
Status: (Failed) 2016-02-01 - From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. [AB34 Detail]
Download: California-2015-AB34-Amended.html
BILL NUMBER: AB 34 AMENDED BILL TEXT AMENDED IN ASSEMBLY MAY 20, 2015 AMENDED IN ASSEMBLY MAY 5, 2015 AMENDED IN ASSEMBLY APRIL 23, 2015 AMENDED IN ASSEMBLY APRIL 20, 2015 AMENDED IN ASSEMBLY MARCH 26, 2015 INTRODUCED BY Assembly Members Bonta and Jones-Sawyer DECEMBER 1, 2014 An act to amend Sections 2220.05, 2242, and 2264 of, and to add Chapter 18 (commencing with Section 26000) to Division 9 of, the Business and Professions Code, to add Section 23028 to the Government Code, to amend Section 11362.775 of the Health and Safety Code, and to add Sections 147.5 and 3094 to the Labor Code, relating to medical cannabis, and making an appropriation therefor. LEGISLATIVE COUNSEL'S DIGEST AB 34, as amended, Bonta. Medical cannabis regulation and enforcement. (1) Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 5, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature, commonly referred to as the Medical Marijuana Program Act (MMPA), requires the establishment of a program for the issuance of identification cards to qualified patients so that they may use marijuana for medical purposes without arrest or prosecution under specified state law, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. This bill would enact the Medical Cannabis Regulation and Control Act and would establish the Division of Medical Cannabis Regulation and Enforcement within the Department of Alcoholic Beverage Control, the Division of Medical Cannabis Manufacturing and Testing within the State Department of Public Health, and the Division of Medical Cannabis Cultivation within the Department of Food and Agriculture and would set forth the duties of the respective regulatory authorities. The bill would, 180 days after the division posts a specified notice on its Internet Web site, make those provisions of the MMPA that prohibit prosecution of qualified patients, persons with valid identification cards, and designated primary caregivers who associate in California, collectively or cooperatively, to cultivate marijuana for medical purposes, inapplicable to licensees. The bill would, thereafter, permit a dispensary to provide patients with medical marijuana and medical marijuana products obtained only from persons licensed under this bill. The bill would require the regulatory authorities to license persons to engage in the various aspects of commercial cannabis activity, as defined. The bill would designate as peace officers specified officers and employees of the regulatory authorities. The bill would prescribe requirements for the issuance, renewal, suspension, and revocation of a mandatory commercial license and would authorize the assessment of related fees. This bill would require medical cannabis and medical cannabis products to be adhere to specified packaging, labeling, and food safety standards. The bill would not preclude a city or county from adopting a local ordinance, not consistent with this bill, that regulates the location, operation, or establishment of a licensee or prohibits commercial cannabis activity within its jurisdiction. The bill would require state agencies to collaborate with localagencies, and would require local agencies to, within the scope of their jurisdiction, assist state agencies in the enforcement of the bill.agencies to enforce the act, to the extent that it is within the scope of other statuary responsibilities of local agencies and to the extent that resources are available to the local agencies. By imposing these enforcement duties on local agencies, the bill would impose a state-mandated local program. The bill would establish the MedicalCannibisCannabis Control Fund with separate accounts forfeesfees, fines, and for penalties, and would require deposit of fees and penalties into their respective accounts within the fund. The bill would continuously appropriate moneys within the fees account to the appropriate regulating authorities for the purposes of administering the program. The bill would authorize the regulatory authorities to collaborate to establish a regulation and enforcement assistance grant program and wouldauthorize the Department of Transportation to conduct research andrequire the Department of the California Highway Patrol to develop protocols regarding determining whether a driver is operating a vehicle under the influence of marijuana to assist law enforcement agencies. The bill would makethespecified fines and penalties deposited into the fund available, upon appropriation by the Legislature, for funding these programs. The bill would require the regulatory authorities, as soon as practicable, to allow qualified applicants for licensure to apply for and receive a provisional license to engage in commercial cannabis activity and to adopt emergency regulations for that purpose. The bill would require the regulatory authorities to adopt regulations necessary for the implementation and enforcement of this bill in consultation with prescribed state agencies relating to environmental, agricultural, consumer protection, worker safety, and food and product safety requirements. The bill would authorize the regulatory authorities to enter into interagency agreements to pay, from fees deposited into the fund, the associated costs incurred by these state agencies. The bill would establish a cannabis employee certification, training, and apprenticeship program for cultivation sites and dispensaries, as defined. The bill would require the Division of Labor Standards Enforcement to maintain and enforce minimum standards for the competency and training of employees and to certify cannabis employees. The bill would require the Division of Occupational Safety and Health by January 1, 2017, to convene an advisory committee to evaluate whether there is a need to develop industry-specific regulations related to the activities of licensed facilities. The bill would require the advisory committee to present to the Occupational Safety and Health Standards Board its findings and recommendations for consideration by the board, and would require the board, by July 1, 2017, to render a decision regarding the adoption of industry-specific regulations. The bill would require a licensee to keep various records in connections with commercial cannabis activities and would prescribe requirements for making records available to the division and any state or local agency. The bill would prohibit the disclosure of certain patient and caregiver information pursuant to the California Public Records Act. The bill would declare that it does not apply to, or diminish the protections granted to, a patient or primary caregiver acting pursuant to the Compassionate Use Act of 1996 and would exempt these parties from the application of the act. The bill would declare that the actions of a licensee or provisional licensee, its employees, and its agents that are within the scope of a valid license are not unlawful under state law, as specified. The bill would provide similar state law immunity for a property owner who allows his or her property to be used by a licensee or provisional licensee. The bill would require the regulatory authorities to work in conjunction with law enforcement entities throughout the state to implement and enforce the rules and regulations regarding medical cannabis and to take appropriate action against businesses and individuals that fail to comply with the law. The bill would authorize the director of any regulatory authority, and prescribed local entities, to bring an action to enjoin violations. The bill would require the regulatory authority to establish a digital database and to permit state and local law enforcement agencies to verify licenses. (2) Existing law, the Medical Practice Act, establishes the Medical Board of California and sets forth its powers and duties, including, but not limited to the licensing and regulation of physicians and surgeons. Existing law sets forth the conduct that would constitute unprofessional conduct for a physician and surgeon, including, but not limited to, prescribing certain drugs without an appropriate examination or medical indication. Existing law generally makes a violation of these provisions a misdemeanor. This bill would specify that recommending marijuana to patients without an appropriate prior examination and a medical indication is unprofessional conduct. The bill would provide that specified acts of recommending marijuana without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the Medical Board of California, as described above. The bill would deem as unprofessional conduct a physician and surgeon being employed by, or entering into an agreement with, a medical cannabis licensee to provide recommendations for medical marijuana. By broadening the definition of a crime, the bill would impose a state-mandated local program. (3) Existing law authorizes the board of supervisors of a county and the governing body of a city to impose various taxes, including a transactions and use tax at a rate of 0.125%, or a multiple thereof, if approved by the required vote of the board or governing body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%. This bill would authorize the board of supervisors of a county or a city council to impose, by ordinance, a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing cannabis or cannabis products, including a transactions and use tax at any rate specified by the board. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement. (4) This bill would specify that its provisions are severable. (5) Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest. This bill would make legislative findings to that effect. (6) The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that with regard to certain mandates no reimbursement is required by this act for a specified reason. With regard to any other mandates, this bill would provide that, if the Commission on State Mandates determines that the bill contains costs so mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above. Vote: majority. Appropriation: yes. Fiscal committee: yes. State-mandated local program: yes. THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS: SECTION 1. The Legislature finds and declares all of the following: (a) The people of California enacted the Compassionate Use Act of 1996 to ensure that seriously ill Californians have access to marijuana for medical purposes. The Compassionate Use Act of 1996 urged the state and federal governments to implement a plan to provide for the safe and affordable distribution of medical marijuana to all patients in medical need of the drug. (b) Under federal law, marijuana is a Schedule 1 drug. Its placement in that schedule is based upon a finding that marijuana has no currently accepted medical use. That finding, if correct at the time it was made, is no longer accurate. California, exercising its traditional power to regulate the practice of medicine, has determined that marijuana has a significant role to play. (c) California, acting alone, is powerless to change federal law and to correct this misunderstanding in federal law about the role that marijuana can and does play in the practice of medicine. However, federal enforcement authorities have recognized that in states that have authorized marijuana use and have enacted strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale, and possession of marijuana, conduct in compliance with those regulatory and enforcement systems is less likely to threaten federal priorities and, thus, less likely to require federal enforcement intervention (See: Memorandum For All United States Attorneys--Guidance Regarding Marijuana Enforcement, by James M. Cole, Deputy Attorney General, August 29, 2013). (d) The purpose of this act is to establish for California a robust medical cannabis regulatory and enforcement system to ensure that conduct in compliance with California's medical marijuana laws does not threaten the federal priorities as set forth in the James M. Cole memorandum, and, therefore, does not require federal enforcement intervention. (e) Nothing in this act or Article 2 (commencing with Section 11357) or Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code is intended to preempt any local ordinance regulating or banning the cultivation, processing, manufacturing, testing, transportation, distribution, provision, donation, or sale of medical cannabis, or to otherwise prevent or limit a city, county, or city and county from adopting or enforcing a zoning ordinance or other law, ordinance, or regulation that bans or regulates the location, operation, or establishment of any individual or other person that cultivates, processes, possesses, stores, manufactures, tests, transports, distributes, provides, donate, or sells cannabis. (f) Nothing in this act is intended to require an employer to permit or accommodate the use, consumption, possession, transfer, display, transportation, sale, or growth of marijuana in the workplace, or to affect the ability of employers to have policies restricting the use of marijuana by employees, or otherwise complying with federal law. SEC. 2. Section 2220.05 of the Business and Professions Code is amended to read: 2220.05. (a) In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph: (1) Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public. (2) Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient. (3) Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions. (4) Sexual misconduct with one or more patients during a course of treatment or an examination. (5) Practicing medicine while under the influence of drugs or alcohol. (b) The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a). (c) The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b). SEC. 3. Section 2242 of the Business and Professions Code is amended to read: 2242. (a) Prescribing, dispensing, or furnishing dangerous drugs as defined in Section 4022 without an appropriate prior examination and a medical indication, constitutes unprofessional conduct. Prescribing or recommending marijuana to a patient for a medical purpose without an appropriate prior examination and a medical indication constitutes unprofessional conduct. (b) No licensee shall be found to have committed unprofessional conduct within the meaning of this section if, at the time the drugs were prescribed, dispensed, or furnished, any of the following applies: (1) The licensee was a designated physician and surgeon or podiatrist serving in the absence of the patient's physician and surgeon or podiatrist, as the case may be, and if the drugs were prescribed, dispensed, or furnished only as necessary to maintain the patient until the return of his or her practitioner, but in any case no longer than 72 hours. (2) The licensee transmitted the order for the drugs to a registered nurse or to a licensed vocational nurse in an inpatient facility, and if both of the following conditions exist: (A) The practitioner had consulted with the registered nurse or licensed vocational nurse who had reviewed the patient's records. (B) The practitioner was designated as the practitioner to serve in the absence of the patient's physician and surgeon or podiatrist, as the case may be. (3) The licensee was a designated practitioner serving in the absence of the patient's physician and surgeon or podiatrist, as the case may be, and was in possession of or had utilized the patient's records and ordered the renewal of a medically indicated prescription for an amount not exceeding the original prescription in strength or amount or for more than one refill. (4) The licensee was acting in accordance with Section 120582 of the Health and Safety Code. SEC. 4. Section 2264 of the Business and Professions Code is amended to read: 2264. The employing, directly or indirectly, the aiding, or the abetting of any unlicensed person or any suspended, revoked, or unlicensed practitioner to engage in the practice of medicine or any other mode of treating the sick or afflicted which requires a license to practice constitutes unprofessional conduct. Employment by, or other agreement with, a mandatory commercial licensee acting pursuant to the Medical Cannabis Regulation and Control Act or a dispensary to provide recommendations for medical marijuana constitutes unprofessional conduct. SEC. 5. Chapter 18 (commencing with Section 26000) is added to Division 9 of the Business and Professions Code, to read: CHAPTER 18. MEDICAL CANNABIS REGULATION AND CONTROL Article 1. General Provisions 26000. (a) This chapter shall be known, and may be cited, as the Medical Cannabis Regulation and Control Act. (b) It is the intent of the Legislature in enacting this chapter to provide for the statewide regulation of the commercial cannabis activity and the enforcement of laws relating to commercial cannabis activities without preempting city or county ordinances regulating or banning these activities. This chapter is an exercise of the police powers of the state for the protection of the safety, welfare, health, peace, and morals of the people of the state. (c) Nothing in this chapter, or any regulations promulgated thereunder, shall be deemed to limit the authority or remedies of a city or county under any provision of law, including, without limitation, Section 26010 or 26060 or Section 7 of Article XI of the California Constitution. 26001. Without limiting the authority of a city or county pursuant to Section 7 of Article XI of the California Constitution, or any other provision of law, and subject to that authority, the state shall have the primary right and power to regulate and license persons for the cultivation, manufacture, transportation, sale, and other related activities regarding medical cannabis within the state. In the exercise of these rights and powers, the state and each of its agencies are hereby deemed not to be engaged in activities requiring licensure under this chapter. 26002. For the purpose of this chapter: (a) "Regulatory authority" means the Division of Medical Cannabis Regulation and Enforcement within the Department of Alcoholic Beverage Control, the Division of Medical Cannabis Manufacturing and Testing within the State Department of Public Health, or the Division of Medical Cannabis Cultivation within the Department of Food and Agriculture, as appropriate to the context. (b) "Regulatory director" means the Director of the Department of Alcoholic Beverage Control, the Director of the Department of Public Health, or the Director of the Department of Food and Agriculture. (c) "Division" means the Division of Medical Cannabis Regulation and Enforcement within the Department of Alcoholic Beverage Control, unless otherwise specified. (d) "Cannabis" means all parts of the plant Cannabis sativa L., cannabis indica, or cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. It does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. "Cannabis" also means marijuana as defined by Section 11018 of the Health and Safety Code as enacted by Chapter 1407 of the Statutes of 1972. (e) "Commercial cannabis activity" means any cultivation, possession, manufacture, processing, storing, laboratory testing, labeling, transporting, distribution, or sale of cannabis or cannabis product, or any Internet platform that facilitates any of these functions for the purpose of selling medical cannabis or medical cannabis products to qualified patients or caregivers, except as set forth in subdivision (b) of Section 26052. (f) "Medical cannabis," "medical cannabis product," "medical marijuana product," or "cannabis product" means any product containing cannabis, including, but not limited to, concentrates and extractions intended to be sold for use by medical marijuana patients in California pursuant to the Compassionate Use Act of 1996 (Proposition 215). (g) "Manufactured cannabis" means raw marijuana that has undergone a process whereby the raw agricultural product has been transformed into a concentrate, an edible product, or a topical product. (h) "Cannabis concentrate" means manufactured cannabis that has undergone a process to concentrate thetetrahydrocannabinolcannabinoid active ingredient, thereby increasing the product's potency. (i) "Cannabinoid" means a chemical compound that is unique to and derived from cannabis, also known as phytocannabinoid. (j) "Edible cannabis product" means manufactured cannabis that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum. (k) "Topical cannabis" means manufactured product intended for external use. (l) "Identification program" means the universal identification certificate program for licensees. (m) "Mandatory commercial license" or "license" means a mandatory commercial license issued pursuant to Article 3 (commencing with Section 26040). (n) "Licensee" means any person licensed under this chapter to engage in commercial cannabis activity related to medical cannabis or medical cannabis products as set forth in this chapter. (o) "Dispensary" means a nonmobile, nonvehicular, non-Internet- based retail location that distributes medical cannabis or medical cannabis products and is owned and operated by a licensee for these activities pursuant to this chapter. (p) "Testing and labeling" means a labeling and quality assurance plan that addresses all of the following: (1) Potency. (2) Chemical residue. (3) Microbiological contaminants. (4) Handling, care, and storage. (5) Date and location of cultivation, processing, and manufacturing. (q) "Fund" means the Medical Cannabis Control Fund established pursuant to Section 26028. (r) "Person" means any individual, firm, partnership, joint venture, association, corporation, limited liability company, estate, trust, business trust, receiver, syndicate, or any other group or combination acting as a unit and includes the plural as well as the singular number. (s) "Cultivation site" means a location that grows medical cannabisor medical cannabis productsand is owned and operated by a licensee for these activities pursuant to this chapter, including a nursery. (t) "Nursery" means a licensee that produces only clones, immature plants, seeds, and other agricultural products used specifically for the planting, propagation, and cultivation of medical cannabis. (u) "Cultivation" means any activity involving the planting, growing, harvesting, drying, processing, or trimming of cannabis. (v) "Dispensing" means any activity involving the retail sale of medical cannabis or medical cannabisproducts.products from a dispensary. (w) "Labor peace agreement" means an agreement between a licensee and a bona fide labor organization that, at a minimum, protects the state's proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicant's business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicant's employees. The agreement shall provide a bona fide labor organization access at reasonable times to areas in which the applicant's employees work, for the purpose of meeting with employees to discuss their right to representation, employment rights under state law, and terms and conditions of employment. This type of agreement shall not mandate a particular method of election or certification of the bona fide labor organization. (x) "Manufacturing site" means a location that conducts the production, preparation, propagation, compounding, or processing of medical cannabis or medical cannabis products, either directly or indirectly or by extraction processes, or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis, and includes a location that packages or repackages medical cannabis or medical cannabis products or labeling or relabeling of its container, and is owned and operated by a licensee for these activities pursuant to this chapter. (y) "Transport" means the commercial transfer of medical cannabis or medical cannabis products from the business location of one mandatory commercial licensee to another mandatory commercial licensee, for the purposes of conducting commercial cannabis activity authorized by licensees pursuant to this chapter. (z) "Delivery" means the commercial transfer of medical cannabis or medical cannabis products from a dispensary to a primary caregiver or qualified patient, as defined in Section 11362.7 of the Health and Safety Code. (aa) "Live plants" means living medical cannabis flowers and plants, including seeds, immature plants, and vegetative stage plants. (ab) "Dried flower" means all dead medical cannabis that has been harvested, dried, cured, or otherwise processed. 26010. This chapter does not, nor does Article 2 (commencing with Section 11357) and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code, prevent a city or county from doing any of the following: (a) Adopting local ordinances inconsistent with this chapter that do the following: (1) Regulate the location, operation, or establishment of a licensee or any person that cultivates, processes, possesses, stores, manufactures, tests, transports, distributes, or sells medical cannabis. (2) Prohibit commercial cannabis activity within their jurisdiction. (b) The administrative, civil, or criminal enforcement of the ordinances described in subdivision (a). (c) Establishing a fee or tax for the operation of a licensee within its jurisdiction. (d) Enacting and enforcing other laws or ordinances pursuant to the authority granted by Section 7 of Article XI of the California Constitution. 26011. (a) All manufactured medical cannabis and medical cannabis products shall be packaged and labeled, and shall adhere to labeling and packaging standards, including, but not limited to, all of the following: (1) All labels shall include the manufacturing date, the name of the mandatory commercial licensee from which it was obtained, the active ingredients, net weight, cannabinoid profile, nutritional facts, any potential allergens, and the amount in milligrams of cannabinoids per serving, servings per package, and the amount in milligrams of cannabinoids in the total package. (2) All labels shall include the warnings: "KEEP OUT OF REACH OF CHILDREN AND ANIMALS," and "FOR MEDICAL USE ONLY." (3) All packaging shall contain a clear indication in bold font that the package contains medical cannabis. (4) All packages shall not be designed in a manner that attracts minors. (5) All labels shall clearly distinguish edible cannabis products from noncannabis products. (6) All packages shall show the name of the mandatory commercial licensee that tested the product, the testing batch number, and the date the test was completed. (b) All medical cannabis and medical cannabis products shall abide by consumer protection, food and product safety requirements, including, but not limited to, all of the following: (1) All manufacturers of medical cannabis and medical cannabis products shall abide by sanitation standards equivalent to the California Retail Food Code (Part 7 (commencing with Section 113700) of Division 104 of the Health and Safety Code) for food preparation, storage, handling, and sale of medical cannabis products. For purposes of this chapter, edible medical cannabis products are deemed to be unadulterated food products. (2) All edible medical cannabis products shall be limited to foods that are not potentially hazardous food as set forth in Section 114365.5 of the Health and Safety Code. (3) All edible medical cannabis products shall be packaged at the original point of preparation. Article 2. Administration 26020. (a) The Division of Medical Cannabis Regulation and Enforcement is hereby established within the Department of Alcoholic Beverage Control. The Division of Medical Cannabis Regulation and Enforcement shall do all of the following: (1) Be administered by a person who is appointed by theDirector of the Department of Alcoholic Beverage Control.Governor. (2) Administer this chapter, as it pertains to commercial cannabis activity relating to dispensaries. (3) Lead all state and local authorities regarding the tracking of medical cannabis, medical cannabis products, and licensees pursuant to this chapter. (b) The Division of Medical Cannabis Manufacturing and Testing is hereby established within the Department of Public Health. The Division of Medical Cannabis Manufacturing and Testing shall do all the following: (1) Be administered by a person who is appointed by theState Health Officer.Governor. (2) Administer this chapter, as it pertains to manufacturing, testing, and certification of testing laboratories for medical cannabis and medical cannabis products. (c) The Division of Medical Cannabis Cultivation is hereby established within the Department of Food and Agriculture. The Division of Medical Cannabis Cultivation shall do all of the following: (1) Be administered by a person who is appointed by theSecretary of the Department of Food and Agriculture.Governor. (2) Administer this chapter as it pertains to cultivation of medical cannabis. (d) The regulatory authorities shall issue licenses to applicants to engage in commercial cannabis activity pursuant to this chapter. No person shall engage in commercial cannabis activity unless the person obtains permission pursuant tosectionSection 26045. (e) The division shall maintain a registry of all permit holders and shall maintain a record of all licenses and commercial cannabis activity of the permit holder throughout the length of licensure and for a minimum of seven years following the expiration of each license. The division shall make limited licensee information available to a licensee so that it may verify whether it is engaging in commercial cannabis activities with a properly licensed entity. (f) Each regulatory authority shall adopt regulations as needed to implement that licensing program as set forth in Article 3 (commencing with Section 26040) within one year following the establishment of provisional licenses, pursuant to Section 26054. The regulations shall not limit the authority of a city or a county pursuant to Section 7 of Article XI of the California Constitution, Section 26010 or 26060, or any other law. The regulations shall, in addition, do all of the following: (1) Establish a scale of application, licensing, and renewal fees, based upon the cost of enforcing this chapter, as follows: (A) Each regulatory authority shall charge each applicant for licensure or renewal an application or renewal fee that shall be calculated to cover the costs of processing the application or renewal. This fee may vary depending upon the varying costs associated with approving the application or renewal related to the varying activities covered by the license, but shall not exceed the reasonable regulatory costs to the regulatory authority. (B) Each regulatory authority shall charge each licensee a licensure fee upon the issuance of a license. The licensure fee shall be calculated to cover the costs of administering this chapter, other than the costs of processing applications. The licensure fee may vary depending upon the varying costs associated with administering the various regulatory requirements of this chapter as they relate to the nature and scope of the different licensure activities, but shall not exceed the reasonable regulatory costs to the regulatory authority. (C) The total fees assessed pursuant to this chapter, including, but not limited to, provisional license fees set forth in Section 26054, shall be set at an amount that will fairly and proportionately generate sufficient total revenue to fully cover the total costs of administering this chapter, including, but not limited to, costs set forth in Section 26023. (2) Establish procedures for approval or denial of applications for licensure for each and every aspect of commercial cannabis activity, including, but not limited to, cultivation, possession, manufacture, processing, storing, laboratory testing, labeling, transporting, distribution, and sale of cannabis. (3) Establish applicant qualifications. (4) Establish licensee employee qualifications, including, but not limited to, training and screening requirements. (5) Establish licensee security requirements, including, but not limited to, procedures to limit access to facilities and to prevent diversion of product to nonmedical use. (6) Establish procedures and protocols for identifying, managing, and disposing of contaminated, adulterated, deteriorated, or excess product. (7) Establish advertising, marketing, signage, and labeling requirements and restrictions. (8) Establish procedures for the suspension, revocation, or surrender of a license and establishing related fines and penalties to be assessed against licensees for violations of this chapter. (9) Establish procedures for the collaborative oversight of thefundfund, and its related accounts, established pursuant to Section 26028. 26020.1. (a) The regulatory authorities, by March 1, 2016, shall convene a task force which shall advise the regulatory authorities on the development of standards pursuant to this chapter. The task force shall be responsible for determining the appropriate roles of each state entity as it pertains to this chapter, and shall establish clear guidelines on communication and information sharing between state entities for implementation of this chapter. Notwithstanding Section 10231.5 of the Government Code, the task force shall submit a report on these standards, determinations, and guidelines for implementation of this chapter, to the Legislature and state entities affected by this chapter by August 1, 2016. The report submitted to the Legislature shall be submitted in compliance with Section 9795 of the Government Code. (b) The task force shall be comprised of representatives of medical cannabis consumer advocates, environmental experts, public health experts, medical cannabis industry representatives, the related regulatory authorities, labor, and law enforcement. The task force may also be comprised of representatives for the State Board of Equalization and Attorney General, and other state agencies, as deemed appropriate. The task force shall have a minimum of nine members, with one-third of the members appointed by the California State Assembly, one-third of the members appointed by the California State Senate, and one-third of the members appointed by the Governor. If there is an unequal divide between these three entities, the Governor shall make appointments for the difference. (c) Task force members shall serve on a voluntary basis and shall be responsible for any costs associated with their participation in the task force. The regulatory authorities shall not be responsible for travel costs incurred by task force members or otherwise compensating task force members for costs associated with their participation in the task force. 26021. For purposes of this chapter, the Secretary of the California Department of Food and Agriculture shall declare medical cannabis to be an agricultural product. The Division of Medical Cannabis Cultivation shall do all of the following: (a) Adopt regulations, in consultation with the State Water Resources Control Board, to ensure that commercial cannabis activity licensed pursuant to this chapter does not threaten the state's clean water and environment. (b) Adopt regulations ensuring that the cultivation of cannabis under this chapter is in compliance with standards equivalent to the statutory and regulatory requirements applicable to the production of a food crop, including, but not limited to, all of the following: (1) Regulations regarding the verification of cannabis stock for the purposes of cultivation. (2) Cultivation protocols ensuring the quality, availability, and safety of the cannabis crop, including both indoor and outdoor cultivation standards and regulations regarding carbon offsets for indoor cultivation. (3) Environmentally sound agricultural practices, including all of the following: (A) A requirement that any actual, or potential for, environmental damage be addressed by the relevant state agency, including, but not limited to, the State Board of Forestry and Fire Protection, the Department of Fish and Wildlife, California regional water quality control boards, the Department of the California Highway Patrol, or the Department of Justice. (B) A provision authorizing suspension or revocation of a licensee if the state determines that the conduct of the licensee threatens to inflict or has inflicted significant damage to the environment. (C) Standards controlling the application of pesticides. These standards shall, at a minimum, require that if pesticides are to be used, the use comply with standards equivalent to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementingregulations.regulations, in compliance with federal law. (c) Adopt regulations to establish cultivation labeling and packaging standards and requirements, including, but not limited to, cultivation labeling requirements requiring labeling to include, at a minimum, cannabinoid levels, cannabinoid profile, and active ingredients. (d) In consultation with the State Department of Public Health, establish testing standards for medical cannabis. (e) Ensure cultivationlicenseslicensees have access to existing agricultural incentive and support programs. (f) Establish weighing or measuring standards, including, but not limited to, the requirement that devices used in connection with the sale or distribution of cannabis meet standards equivalent to Division 5 (commencing with Section 12001).(g) Establish standards controlling the application of pesticides. These standards shall, at a minimum, require that if pesticides are to be used, the use comply with standards equivalent to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.(g) Assess an administrative fine upon a licensee for each violation of any regulation promulgated pursuant to subdivision (a) to (c), inclusive, in an amount equal to the costs to remedy any environmental damage caused by the violation or violations. (h) In consultation with other regulatory authorities, establish transportation and delivery standards for manufactured medical cannabis and medical cannabis products, including standards related to the transport and delivery of perishable and nonperishable medical cannabis and medical cannabis products. (i) Adopt any other regulations necessary to fully implement the provisions of this chapter related to the cultivation of medical cannabis. 26021.5. (a) State agencies shall collaborate with localagencies, and local agencies, within the scope of their jurisdiction, and to the extent that resources are available, shall assist state agencies in the enforcement of this chapter.agencies to enforce this chapter to the extent that it is within the scope of other statutory responsibilities of local agencies and to the extent that resources for this enforcement are available to the local agencies. This section shall not limit any other state or local requirements. (b)No cannabis shallCannabis shall not be cultivated on public lands pursuant to this chapter. 26022. The Division of Medical Cannabis Manufacturing and Testing shall adopt regulationsto dofor all of the following:(a) Establish product labeling and packaging standards and requirements, including, but shall not be limited to, all of the following:(1) All manufactured cannabis product labeling and packaging standards, including, but not limited to, all of the following:(A) A requirement that the label include the manufacturing date, the name of the mandatory commercial licensee from which it was obtained, the active ingredients, net weight, cannabinoid profile, nutritional facts, any potential allergens, and the amount in milligrams of cannabinoids per serving, servings per package, and the amount in milligrams of cannabinoids in the total package.(B) A requirement that the label include the warnings: "KEEP OUT OF REACH OF CHILDREN AND ANIMALS," and "FOR MEDICAL USE ONLY."(C) A requirement that packaging contain a clear indication in bold font that the package contains medical cannabis, and that the package not be designed in a manner that attracts minors.(D) Standards for labeling food that clearly distinguish edible cannabis products from non-cannabis products.(E) The name of the mandatory commercial licensee that manufactured the product.(b) Establish consumer protection, food and product safety requirements, including, but not limited to, all of the following:(1) Adverse event reporting and product recall systems that include batch, lot, or control number tracking, the requirement that employees who manufacture or otherwise handle edible medical cannabis products thoroughly wash their hands before commencing production and before handling finished edible medical cannabis products.(2) Standards for the amount, in milligrams, of cannabinoids per serving in edible products.(3) Sanitation standards equivalent to the California Retail Food Code (Part 7 (commencing with Section 113700) of Division 104 of the Health and Safety Code) for food preparation, storage, handling, and sale of medical cannabis products. For purposes of this chapter, edible medical cannabis products are deemed to be unadulterated food products.(4) A requirement that edible medical cannabis products be limited to foods that are not potentially hazardous food as set forth in Section 114365.5 of the Health and Safety Code.(5) Standards controlling the application of pesticides. These standards shall, at a minimum, require that if pesticides are to be used, the use comply with standards equivalent to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.(6) A requirement that all edible medical cannabis products shall be individually wrapped at the original point of preparation.(c) Establish testing(a) Testing requirements for all medical cannabis and medical cannabis products, including edible cannabis products and those used, or intended for use, via inhalation, including, but not limited to: (1) Testing for the active cannabinoid-profile, constituent elements, and microbiological, bacterial, pathogenic yeast, and mold counts. (2) Testing standards by which to test and measure the potency of medical cannabis and medical cannabis products. The Division of Medical Cannabis Manufacturing and Testing shall also determine maximumstandards in the potency of medical cannabis andpotency standards for medical cannabis products. (3) Testing standards by which to test and measure the quality of the medical cannabis and medical cannabis product. (4) Protocols for medical cannabis and medical cannabis product safety testing.(d) Establish procedures(b) Procedures for certifying laboratories for the testing of medical cannabis and medical cannabis products, as defined in this chapter. Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, including, but not limited to, ISO/IEC 17020 and 17025. The Department of Medical Cannabis Manufacturing and Testing may use an outside accreditation body, approved by the International Laboratory Accreditation Cooperation, to assist in certification of laboratories. (c) Consumer protection standards for manufactured medical cannabis and medical cannabis products, including, but not limited to, the following: (1) Adverse event reporting and product recall systems that include batch, lot, or control number tracking, and the requirement that employees who manufacture or otherwise handle edible medical cannabis products thoroughly wash their hands before commencing production and before handling finished edible medical cannabis products. (2) Standards for the amount, in milligrams, of cannabinoids per serving in edible products. (d) Safety protocols and standards of protocol for all levels of manufacturing medical cannabis and medical cannabis products. (e) In consultation with other regulatory authorities, transportation and delivery standards for manufactured medical cannabis and medical cannabis products, including standards related to the transport and delivery of perishable and nonperishable medical cannabis and medical cannabis products. (f) Any other regulations necessary to fully implement the provisions of this chapter related to the manufacturing and testing of medical cannabis and medical cannabis products. 26023. The division shall adopt regulations for all of the following: (a) Minimum educational and testing requirements for dispensary licensee staff, including, but not limited to, background checks and a requirement that every dispensary maintain dedicated, licensed security staff, as deemed appropriate by the division. (b) Inventory and control protocols. (c) Protocols for the safe, secure storage of medical cannabis and medical cannabis products by wholesale and dispensary licensees. (d) Maximum allowed storage for dispensaries and wholesale sites of medical cannabis and medical cannabis products. (e) In consultation with other regulatory authorities, transportation and delivery standards for medical cannabis and medical cannabis products, including standards related to the transport and delivery of perishable and nonperishable medical cannabis and medical cannabis products. (f) Any other regulations necessary to fully implement the provisions of this chapter related to the dispensing of medical cannabis and medical cannabis products.26023.26023.5 The regulations shall set forth the inspection and enforcement responsibilities of the Department of Alcohol and Beverage Control, the State Department of Public Health, the Division of Labor Standards Enforcement, the State Water Resources Control Board, the State Department of Public Health, and the Department of Food and Agriculture associated with this chapter.26023.5. (a) Without limiting the authority of a city or a county pursuant to Section 7 of Article XI of the California Constitution or any other law, the Division of Medical Cannabis Regulation and Enforcement shall adopt regulations regarding the minimum standards for the operation of dispensaries. The regulations shall establish all of the following: (1) A requirement that dispensaries provide patients with detailed written information about the contents of the cannabis and medical cannabis products they obtain. (2) Requirements for inventory control and reporting that require all dispensaries to be able to demonstrate the present location, amounts, and descriptions of all medical cannabis products from the time of delivery to the dispensary until purchase by a qualified patient or primary caregiver. (3) Minimum educational and testing requirements for licensee staff, including, but not limited to, background checks and a requirement that every dispensary maintain dedicated, licensed security staff as deemed appropriate by the division. (4) Minimum standards governing signage and advertising for dispensaries. (b) Commencing 180 days after the division begins issuing provisional licenses, a dispensary shall provide patients medical cannabis and medical cannabis products obtained only from persons licensed under this chapter. (c) Out-of-state medical cannabis patients with current, valid verification that they are allowed to receive medical cannabis treatment within their home state may receive medical cannabis treatment, including the ability to purchase medical cannabis from licensed dispensaries within this state upon verification of the documents by the dispensary, pursuant to protocols established by the division.26024. The regulatory authorities may assist state taxation authorities in the development of uniform policies for the state taxation of mandatory commercial licensees. 26028. (a) The Medical Cannabis Control Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the moneys in the fund. (b) All license fees collected by the Division of Medical Cannabis Cultivation pursuant to this chapter shall be deposited into thefees account,Medical Cannabis Cultivation Fees Account, which is hereby established within the fund. Notwithstanding Section 13340 of the Government Code, all moneys withinthe feesthis account are hereby continuously appropriated, without regard to fiscal year, to theappropriate regulatory authorityDivision of Medical Cannabis Cultivation solely for the purposes of fully funding and administering this chapter, including, but not limited to, the costs incurred by theregulatory authorityDivision of Medical Cannabis Cultivation for its administrative expenses and costs and the costs of regulation as set forth in Section26023.26021. (c) All administrative fines collected pursuant to subdivision (g) of Section 26021 shall be deposited into the Environmental Safety Account, which is hereby established within the fund, and shall be available, upon appropriation by the Legislature, to the Division of Medical Cannabis Cultivation for allocation to state and local agencies and law enforcement to remedy the environmental impacts of cannabis cultivation. (d) All license fees collected by the Division of Medical Cannabis Manufacturing and Testing pursuant to this chapter shall be deposited into the Medical Cannabis Manufacturing Fees Account, which is hereby established within the fund. Notwithstanding Section 13340 of the Government Code, all moneys within the Medical Cannabis Manufacturing Fees Account are hereby continuously appropriated, without regard to fiscal year to the Division of Medical Cannabis Manufacturing and Testing, solely for the purposes of fully funding and administering this chapter, including, but not limited to, the costs incurred by the Division of Medical Cannabis Manufacturing and Testing for its administrative expenses and costs and the costs of regulation as set forth in Section 26022. (e) All license fees collected by the division pursuant to this chapter shall be deposited into the Medical Cannabis Retail Fees Account, which is hereby established within the fund. Notwithstanding Section 13340 of the Government Code, all moneys within the Medical Cannabis Retail Fees Account are hereby continuously appropriated, without regard to fiscal year, to the division, solely for the purposes of fully funding and administering this chapter, including, but not limited to, the costs incurred by the division for its administrative expenses and costs and the costs of regulation as set forth in Section 26023.(c) All(f) Except as otherwise provided in subdivision (c) and in Section 26064, all moneys collected pursuant to this chapter as a result of fines or penalties imposed under this chapter shall be deposited directly into thefines and penalties account,Medical Cannabis Cultivation Fines and Penalties Account, Medical Cannabis Manufacturing Fines and Penalties Account, and Medical Cannabis Retail Fines and Penalties Account, respectively, whichisare hereby established within the fund, and shall be available, upon appropriation by the Legislature, to the division, the Division of Medical Cannabis Cultivation, and the Divis ion of Manufacturing and Testing, respectively, for the purposes of funding the enforcement grant program pursuant to subdivision (d).(d) The regulatory authorities shall collaboratively(g) Each regulatory authority shall establish and administer a grant program to allocate moneys from the fines and penalties account to state and local entities for the purpose of assisting with medical cannabis regulation and the enforcement of this chapter and other state and local laws applicable tolicensees.cannabis activities. The costs of the grant program under this subdivision shall, upon appropriation by the Legislature, be paid for with moneys in the fines and penalties account.(e)(h) TheDepartment of Transportation shall conduct research regarding determiningDepartment of the California Highway Patrol shall establish protocols to determine whether a driver is operating a vehicle under the influence of cannabis, and shall develop protocols setting forth best practices to assist law enforcement agencies. The costs of theDepartment of TransportationDepartment of the California Highway Patrol under this subdivision shall, upon appropriation by the Legislature, be paid for with equal appropriations from moneys in the fines and penaltiesaccount.accounts.(f)(i) The total fees charged pursuant to this chapter shall be sufficient to pay the costs associated with the administrative and enforcement duties of thedivisionregulatory authorities and of the associated state agencies in administering this chapter.(g)(j) The regulatory authorities shall enter into an interagency agreement with the Department of Alcohol and Beverage Control, the Division of Labor Standards Enforcement, theDepartment of Water Resources,State Water Resources Control Board, the State Department of Public Health, and the Department of Food and Agriculture setting forth the duties of those agencies under this chapter and providing for reimbursement to the appropriate state and local authorities of associated costs from revenues deposited into the fees account of the fund. 26030. (a) The regulatory directors and the persons employed by the regulatory authorities for the administration and enforcement of this chapter are peace officers in the enforcement of the penal provisions of this chapter, the rules of the division adopted under this chapter, and any other penal provisions of law of this state prohibiting or regulating the cultivation, processing, storing, manufacturing, testing, transporting, or selling of medical cannabis, and these persons are authorized, while acting as peace officers, to enforce any penal provisions of state law while in the course of their employment. (b) The regulatory directors, the persons employed by the regulatory authorities for the administration and enforcement of this chapter, peace officers listed in Section 830.1 of the Penal Code, and those officers listed in Section 830.6 of the Penal Code while acting in the course and scope of their employment as peace officers may, in enforcing this chapter, visit and inspect the premises of any licensee at any time during which the licensee is acting pursuant to the mandatory commercial license. (c) Peace officers of the Department of the California Highway Patrol, members of the University of California and California State University police departments, and peace officers of the Department of Parks and Recreation, as defined in subdivisions (a), (b), (c), and (f) of Section 830.2 of the Penal Code, may, in enforcing this chapter, visit and inspect the premises of any licensee at any time during which the licensee is acting pursuant to the license. 26034. (a) Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the regulatory authorities for the purposes of administering this chapter are confidential and shall not be disclosed pursuant to the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code), except as necessary for authorized employees of the State of California or any city or county to perform official duties pursuant to this chapter, or a local ordinance adopted in accordance with Section 26010. (b) Nothing in this section precludes the following: (1) Employees of any of the regulatory authorities notifying state or local agencies about information submitted to the regulatory authority that the employee suspects is falsified or fraudulent. (2) Notifications from any of the regulatory authorities to state or local agencies about apparent violations of this chapter or any applicable local ordinance. (3) Verification of requests by state or local agencies to confirm licenses and certificates issued by the regulatory authorities or other state agency. (4) Provision of information requested pursuant to a court order or subpoena issued by a court or an administrative agency or local governing body authorized by law to issue subpoenas. (c) Information shall not be disclosed by any state or local agency beyond what is necessary to achieve the goals of a specific investigation, a notification, or the parameters of a specific court order or subpoena. 26035. Thischapter doeschapter and Article 2 (commencing with Section 11357) and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code do not require an employer to permit or accommodate the use, consumption, possession, transfer, display, transportation, sale, or growth of cannabis in the workplace ortoaffect the ability of employers to have policies restricting the use of cannabis byemployees.employees, or prevent employers from complying with federal law. Article 3. Mandatory Commercial License 26040. (a) Theregulatory authorities shall adopt regulations establishing a tiered licensing scheme to accommodate the different levels and types of activity to be licensed, as follows:following licenses are allowable for commercial cannabis activity, pursuant to an authorization by a regulatory authority:(1) The Division of Medical Cannabis Cultivation shall adopt regulations for a tiered licensing structure for the cultivation of medical cannabis.(2) The Division of Medical Cannabis Manufacturing and Testing shall adopt regulations for the tiered licensing structure of the following:(A) Manufacturing of medical cannabis products.(B) Testing of medical cannabis products.(C) Certification of medical cannabis testing laboratories.(3) The Division of Medical Cannabis Regulation and Enforcement shall adopt regulations for the tiered licensing structure for all the following:(A) Wholesale of medical cannabis products, which shall include large-scale storage and distribution, as defined by the regulatory authority.(B) Dispensing of medical cannabis products.(1) Licenses authorized by the Division of Medical Cannabis Cultivation are as follows: (A) Type 1, or "specialty outdoor," for outdoor cultivation of less than 5,000 square feet of total area on one property. Maximum of 50 mature plants on the property. (B) Type 1A, or "specialty indoor," for indoor cultivation of less than 5,000 square feet of total area on one property. Maximum of 50 mature plants on the property. (C) Type 2, or "small outdoor," for outdoor cultivation between 5,001 and 10,000 square feet of total area on one property. Maximum of 99 mature plants on the property. (D) Type 2A, or "small indoor," for indoor cultivation between 5,001 and 10,000 square feet of total area on one property. Maximum of 99 mature plants on the property. (E) Type 3, or "medium outdoor," for outdoor cultivation between 10,001 and 30,000 square feet of total area on one property. Maximum of 299 mature plants on the property. The Division of Medical Cannabis Cultivation shall limit the number of licenses allowed of this type. (F) Type 3A, or "medium indoor," for indoor cultivation between 10,001 and 30,000 square feet of total area on one property. Maximum of 299 mature plants on the property. The Division of Medical Cannabis Cultivation shall limit the number of licenses allowed of this type. (G) Type 4, or "large outdoor," for outdoor cultivation greater than 30,001 square feet of total area on one property. Maximum of 500 mature plants on the property. The Division of Medical Cannabis Cultivation shall limit the number of licenses allowed of this type. (H) Type 5, or "nursery," for cultivation of medical cannabis solely as a nursery. Type 5 licensees may transport live plants. (2) Licenses authorized by the Division of Medical Cannabis Manufacturing and Testing are as follows: (A) Type 6A, or "small manufacturing level 1," for manufacturing sites that use a maximum of ____ pounds of medical cannabis each year to produce medical cannabis products, using nonvolatile solvents. (B) Type 6B, or "small manufacturing level 2," for manufacturing sites that use a maximum of ____ pounds of medical cannabis each year to produce medical cannabis products, using volatile solvents. (C) Type 7A, or "large manufacturing level 1," for manufacturing sites that use a maximum of ____ pounds of medical cannabis each year to produce medical cannabis products, using nonvolatile solvents. The Division of Medical Cannabis Manufacturing and Testing shall limit the number of licenses of this type. (D) Type 7B, or "large manufacturing level 2," for manufacturing sites that use a maximum of ____ pounds of medical cannabis each year to produce medical cannabis products, using volatile solvents. The Division of Medical Cannabis Manufacturing and Testing shall limit the number of licenses of this type. (E) Type 8, or "testing," for testing of medical cannabis and medical cannabis products. Type 8 licensees shall have their facilities certified according to regulations set forth by the Division of Medical Cannabis Manufacturing and Testing. (3) Licenses authorized by the division are as follows: (A) Type 9, or "wholesale," for the storage of medical cannabis or medical cannabis products. Maximum storage shall be two pounds of dried flower or 200 individual units per medical cannabis product. (B) Type 10, or "small dispensary," for dispensaries with 1-50 employees, including management. (C) Type 10D, or "small dispensary-delivery," for dispensaries with the same restrictions as Type 10; also allows for delivery. (D) Type 11, or "medium dispensary," for dispensaries with 51-100 employees, including management. (E) Type 11D, or "medium dispensary-delivery," for dispensaries with the same restrictions as Type 11; also allows for delivery. (F) Type 12, or "large dispensary," for dispensaries with 100 employees or greater, including management. (G) Type 12D, or "large dispensary-delivery," for dispensaries with the same restrictions as Type 12; also allows for delivery. (4) (A) Licensees may only hold up to two separate license categories, as follows: (i) Type 1, 1A, and 5 licensees may apply for type 6A, 6A, 7A, and 7B licenses or type 10, 11, 12 licenses. (ii) Type 6A, 6A, 7A, and 7B licensees may apply for type 1, 1A, and 5 licenses or type 10, 10D, 11, 11D, 12, and 12D licenses. (iii) Type 10, 11, and 12 licensees may apply for type 1, 1A, and 5 licenses or type 6A, 6B, 7A, and 7B licenses. (iv) Type 10D, 11D, and 12D licensees may apply for type 6A, 6B, 7A, and 7B licenses. (B) Types 2, 2A, 3, 3A, 4, and 8 licensees shall not hold licenses in any other category. (C) Type 9 licensees may apply only for one additional license from either the cultivation, manufacturing, or dispensing category. (b) Theregulations shallregulatory authorities shall adopt regulations to set forth the application and licensure process, including, but not limited to, all of the following: (1) A description of the various specific forms of commercial cannabis activity to be authorized by the various types of licenses. (2) The establishment of license application, issuance, renewal, suspension, surrender, and revocation procedures for the various types of licenses to be issued. (3) The procedures for the issuance, renewal, suspension, and revocation of mandatory commercial licenses. (4) Time periods, not to exceed 90 days, by which the division shall approve or deny an application for mandatory commercial licensure. The failure of the regulatory authority to act upon an application for licensure within the time prescribed shall not be deemed approval of the application. (5) Qualifications for licensees. (6) Security requirements, including, but not limited to, procedures for limiting access to facilities and for the screening of employees. (c) Each mandatory commercial license application approved by the respective licensing authority pursuant to this chapter is separate and distinct. (d) A mandatory commercial license application approved by the respective licensing authority pursuant to this chapter shall be valid for a period not to exceed one year from the date of approval unless revoked or suspended earlier than that date pursuant to this chapter or the rules or regulations adopted pursuant to this chapter. (e) Each regulatory authority may adopt regulations for additional licenses for any cannabis activity within its statutory jurisdiction pursuant to this chapter, as deemed necessary. (f) Each mandatory commercial license application approved by the respective regulatory authority shall be reported to theDivision of Medical Cannabis Regulation and Enforcementdivision within 24 hours of its approval.26041. Regulations adopted by the regulatory authorities shall require, at a minimum, all of the following, as applicable: (a) The Division of Medical Cannabis Cultivation shall adopt regulations for cultivation of medical cannabis that do all of the following: (1) Require that the cultivation licensee comply with all regulations of the Department of Food and Agriculture pursuant to this chapter regarding the cultivation of medical cannabis. (2) Require that the cultivation licensee comply with any other applicable requirement pursuant to this chapter. (3) Establish criteria for different tiers of cultivation licenses, including, but not limited to small, mid-sized, and large commercial cultivation licenses, based on the area, in square feet, in cannabis cultivation. (4) Authorize commercial cultivation licensees to transport and deliver medical cannabis for commercial purposes to only another licensee of commercial cannabis activity pursuant to this chapter. Cultivation licensees, without a separate dispensary license, who deliver directly to any entity not licensed pursuant to this chapter shall be fined and be under review for the revocation of licensure by the Division of Medical Cannabis Cultivation. (5) Require licensees to track all cannabis products and report to the division, as specified by this chapter and any regulations promulgated pursuant to this chapter. (6) Require a cultivation licensee to obtain a seller's permit from the Board of Equalization to validate the authority of the licensee to sell commercial cannabis products to another licensee of commercial cannabis activity. (7) Require a cultivation licensee to obtain a resale certificate upon the sale of cannabis to another licensee of commercial cannabis activity, to track the quantities exchanged. (8) Require all medical cannabis to be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to commercial exchange with a dispensary. If the licensee has a separate dispensary license, all medical cannabis and medical cannabis products must be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to retail directly to consumers. (9) Ensure cultivation licensees have access to existing agricultural incentive and support programs. (b) The Division of Medical Cannabis Manufacturing and Testing shall adopt regulations for testing of medical cannabis that do all of the following: (1) Prohibit a testing licensee from receiving medical cannabis products except through a regulatory authority or a medical cannabis licensee. (2) Prohibit a testing licensee from being licensed for any other activity authorized under this article, and from holding an ownership interest in any real property, personal property, or other assets associated or used in any other license category. (3) Require the licensee to follow any other applicable requirement of the division pursuant to this chapter. (c) Regulations on the manufacturing of medical cannabis shall do all of the following: (1) Require the manufacturing licensee comply with all regulations of the State Department of Public Health pursuant to this chapter regarding the manufacturing and testing of medical cannabis. (2) Require the manufacturing licensee comply with any other applicable requirement pursuant to this chapter. (3) Establish criteria for different tiers of manufacturing licenses, including, but not limited to small, mid-sized, and large commercial manufacturing licenses. (4) Authorize commercial manufacturing licensees to transport and deliver medical cannabis for commercial purposes to only another licensee of commercial cannabis activity pursuant to this chapter. Manufacturing licensees, without a separate dispensary license, who deliver directly to any entity not licensed pursuant to this chapter shall be fined and be under review for the revocation of licensure by the Division of Medical Cannabis Manufacturing and Testing. (5) Require licensees to track all cannabis products and report to the Division of Medical Cannabis Regulation and Enforcement, as specified by this chapter and any regulations promulgated pursuant to this chapter. (6) Require a manufacturing licensee to obtain a seller's permit from the Board of Equalization to validate the authority of the licensee to sell commercial manufactured cannabis products to another licensee of commercial cannabis activity. (7) Require a manufacturing licensee to obtain a resale certificate upon the sale of manufactured medical cannabis products to another licensee of commercial cannabis activity, to track the quantities exchanged. (8) Require all manufactured medical cannabis and medical cannabis products to be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to commercial exchange with a dispensary. If the licensee has a separate dispensary license, all manufactured cannabis and medical cannabis products shall be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to retail sale directly to consumers. (d) The division shall adopt regulations for the dispensing of medical cannabis that do all of the following: (1) Require the dispensary licensee comply with all regulations of the division pursuant to this chapter regarding the dispensing of medical cannabis (2) Require the dispensary licensee comply with any other applicable requirements pursuant to this chapter. (3) Allow dispensary licensees to store limited quantities of medical cannabis and medical cannabis products for commercial purposes pursuant to this chapter, in a manner deemed safe and secure by the regulatory authority. (4) Allow all non-mobile, non-vehicular, and non-Internet-based dispensaries to be licensed to transport medical cannabis and medical cannabis products directly to consumers. (5) Require all mobile, vehicular and Internet-based dispensaries to maintain a business contract with a non-vehicular and non-mobile dispensary, and report all records of commercial activity to said entity. (6) Require licensees to track all medical cannabis and medical cannabis products and report to the division, as specified by this chapter and any regulations promulgated pursuant to this chapter. (7) Require all dispensary licensees to obtain a seller's permit from the Board of Equalization to validate the authority of the licensee to sell medical cannabis and medical cannabis products, and to maintain receipts of all sales transactions. (8) Require that, upon receipt of medical cannabis, manufactured medical cannabis, and medical cannabis products, the dispensary licensee shall request and record evidence that the product has been tested by a laboratory that has been certified and licensed pursuant to this chapter. (e) Regulations for the wholesale of medical cannabis or medical cannabis products shall do all of the following: (1) Require all wholesale licensees to comply with all regulations of the division pursuant to this chapter regarding the wholesale storage and distribution of medical cannabis. (2) Require the wholesale licensee comply with any other applicable requirements of the division pursuant to this chapter. (3) Establish criteria for the qualifications of a wholesale licensee, including maximum quantities of medical cannabis that each licensee may store at one time. (4) Authorize all wholesale licensees to do commercial business with only other licensees of commercial cannabis activity. All other licensees under this chapter shall not be required to work only with a wholesale licensee directly. (5) Require that all medical cannabis and medical cannabis products be tested by a laboratory that has been certified and licensed pursuant to this chapter prior to commercial exchange with a dispensary. If the licensee has a separate dispensary license, all medical cannabis and medical cannabis products must be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to retail directly to consumers. (6) Require licensees to track all medical cannabis and medical cannabis products and report to the Division on Medical Cannabis Regulation and Enforcement, as specified by this chapter and any regulations promulgated pursuant to this chapter. (f) All regulations related to transportation of cannabis shall require a medical cannabis licensee to do all of the following: (1) Maintain intrastate operating authority. (2) Maintain interstate operating authority, for the commercial purposes of the licensee, and only to the extent permitted by federal law. (3) Be allowed by local jurisdictions to transport medical cannabis, if the licensee is in compliance with this chapter.26041. (a) All licensees authorized by the Division of Medical Cannabis Cultivation for the cultivation of medical cannabis or medical cannabis products shall: (1) Comply with all regulations of the Department of Food and Agriculture pursuant to this chapter regarding the cultivation of medical cannabis. (2) Comply with any other applicable requirements of this chapter. (3) Transport only medical cannabis or medical cannabis products for commercial purposes to only another licensee of commercial cannabis activity pursuant to this chapter. Cultivation licensees that deliver directly to any entity not licensed pursuant to this chapter shall be fined and be under review for the revocation of licensure by the Division of Medical Cannabis Cultivation. Licensees that are not authorized to transport live plants explicitly by their license that transport or deliver live plants shall be fined and be under review for the revocation of licensure by the Division of Medical Cannabis. (4) Track all cannabis products and report to the division, as specified by this chapter and any regulations promulgated pursuant to this chapter. (5) Obtain a seller's permit from the State Board of Equalization to validate the authority of the licensee to sell commercial cannabis products to another licensee of commercial cannabis activity. (6) Obtain a resale certificate upon the sale of cannabis to another licensee of commercial cannabis activity, to track the quantities exchanged. (7) Test all medical cannabis by a laboratory that has been certified and licensed pursuant to this chapter, prior to commercial exchange with a dispensary. If the licensee has a separate dispensary license, all medical cannabis and medical cannabis products must be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to retail directly to consumers. (b) All licensees authorized under the Division of Medical Cannabis Manufacturing and Testing for the manufacturing or testing of medical cannabis or medical cannabis products shall: (1) With regard to testing licensees only: (A) Not receive medical cannabis or medical cannabis products except through a regulatory authority or a licensee of commercial cannabis activity. (B) Not be licensed for any other activity authorized under this article, and from holding an ownership interest in any real property, personal property, or other assets associated or used in any other license category. (2) With regard to manufacturing licensees only: (A) Transport medical cannabis or medical cannabis products for commercial purposes only to another licensee of commercial cannabis activity pursuant to this chapter. Manufacturing licensees, without a separate dispensary license, that deliver directly to any entity not licensed pursuant to this chapter shall be fined and be under review for the revocation of licensure by the Division of Medical Cannabis Manufacturing and Testing. (B) Obtain a seller's permit from the State Board of Equalization to validate the authority of the licensee to sell commercial manufactured cannabis products to another licensee of commercial cannabis activity. (C) Obtain a resale certificate upon the sale of manufactured medical cannabis products to another licensee of commercial cannabis activity, to track the quantities exchanged. (3) With regard to all licensees: (A) Follow any other applicable requirement of this chapter. (B) Comply with all regulations of the State Department of Public Health pursuant to this chapter regarding the manufacturing and testing of medical cannabis. (C) Track all medical cannabis and medical cannabis products and report to the division, as specified by this chapter and any regulations promulgated pursuant to this chapter. (D) Test all manufactured medical cannabis by a laboratory that has been certified and licensed pursuant to this chapter, prior to commercial exchange with a dispensary. If the licensee has a separate dispensary license, all medical cannabis and medical cannabis products must be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to retail directly to consumers. (c) All licensed authorized by the division shall: (1) Comply with all regulations of the division pursuant to this chapter regarding the dispensing of medical cannabis. (2) Comply with any other applicable requirements of this chapter. (3) Track all medical cannabis and medical cannabis products and report to the division, as specified by this chapter and any regulations promulgated pursuant to this chapter. (4) Licenses that are authorized to deliver medical cannabis and medical cannabis products may deliver medical cannabis and medical cannabis products that have been prepared in compliance with this chapter directly to qualified patients and primary caregivers. (5) Test all medical and medical cannabis products by a laboratory that has been certified and licensed pursuant to this chapter prior to commercial exchange with a dispensary. If the licensee has a separate dispensary license, all medical cannabis and medical cannabis products must be tested by a laboratory that has been certified and licensed pursuant to this chapter, prior to retail directly to consumers. (6) With regard to dispensary licensees only: (A) Dispensary licensees may store limited quantities of medical cannabis and medical cannabis products, as determined by the division for commercial purposes pursuant to this chapter, in a manner deemed safe and secure by the division. (B) Out-of-state medical cannabis patients with current, valid verification that they are allowed to receive medical cannabis treatment within their home state may receive medical cannabis treatment, including the ability to purchase medical cannabis from licensed dispensaries within this state upon verification of the documents by the dispensary, pursuant to protocols established by the division, and in accordance with this chapter. (C) Obtain a seller's permit from the Board of Equalization to validate the authority of the licensee to sell medical cannabis and medical cannabis products, and to maintain receipts of all sales transactions. (D) Upon receipt of medical cannabis, manufactured medical cannabis, and medical cannabis products, request and record evidence that the product has been tested by a laboratory that has been certified and licensed pursuant to this chapter. (E) Provide patients with detailed written information about the contents of the medical cannabis and medical cannabis products they obtain. (F) Commencing 180 days after the division begins issuing provisional licenses, provide patients medical cannabis and medical cannabis products obtained only from persons licensed under this chapter. (G) Be able to demonstrate the present location, amounts, and descriptions of all medical cannabis and medical cannabis products from the time of delivery to the dispensary until purchase by a qualified patient or primary caregiver. (7) With regard to wholesale licensees only: (A) Comply with all regulations of the division pursuant to this chapter regarding the wholesale storage and distribution of medical cannabis. (B) Comply with any other applicable requirements of this chapter. (C) Wholesale licensees may do commercial business only with other licensees of commercial cannabis activity. All other licensees under this chapter shall not be required to work only with a wholesale licensee directly. (8) With regard to licensees authorized to transport or deliver medical cannabis or medical cannabis products: (A) Maintain intrastate operating authority. (B) Maintain interstate operating authority, for the commercial purposes of the licensee, and only to the extent permitted by federal law. (C) Be allowed by local jurisdictions to transport medical cannabis, if the licensee is in compliance with this chapter. (D) Only transport or deliver dried flower medical cannabis or medical cannabis products, unless otherwise specified by their license. 26041.5. (a) All licensees under this chapter shall: (1) Abide by the guidelines for the destruction of contaminated, adulterated, deteriorated, or excess medical cannabis or medical cannabis product as follows: (A) Liquid waste shall be disposed of in compliance all applicable federal, state and local laws, regulations, rules, and other requirements. (B) Disposal of chemical, dangerous or hazardous waste shall be conducted in a manner consistent with federal, state and local laws, regulations, rules, or other requirements. This may include, but is not limited to, the disposal of all pesticide or other chemicals used in the cultivation process, certain solvents or other chemicals used in the production of medical cannabis concentrate or any medical cannabis soaked in a flammable solvent for purposes of producing a medical cannabis concentrate. (C) All waste, including infused-product waste, shall be made unusable and unrecognizable prior to leaving the business location of the licensee. Waste may be made unrecognizable by grinding and incorporating the medical cannabis waste with nonconsumable, solid waste, with at least 50 percent of the mixture being nonmedical cannabis, such as paper, plastic, cardboard, food, grease or other compostable oil, bokashi or other compost activators, soil, or any other wastes approved by the regulatory authorities. (D) Any other protocols set forth by the regulatory authorities. (2) Meet minimum advertising, marketing, signage, and lighting requirements as follows: (A) Signs or other advertising matter used in connection with the licensed premises of any licensee shall not be of any obnoxious, gaudy, blatant, of offensive nature, shall not appeal to minors, and shall in no manner contrary to the rules of the department obstruct the view of the interior of the premises from the street. (B) No more than 33 percent of the square footage of the windows and clear doors of the business premises of a licensee shall bear advertising or signs of any sort, and all advertising and signage shall be placed and maintained in a manner that ensures that law enforcement personnel have a clear and unobstructed view of the interior of the premises, including the area in which the cash registers are maintained, from the exterior public sidewalk or entrance to the premises. This latter requirement shall not apply to premises where there are no windows, or where existing windows are located at a height that precludes a view of the interior of the premises to a person standing outside the premises. (C) The exterior of the premises, including adjacent public sidewalks and all parking lots under the control of the licensee, shall be illuminated during all hours of darkness during which the premises are open for business in a manner so that persons standing in those areas at night are identifiable by law enforcement personnel. The required illumination shall be placed so as to minimize interference with the quiet enjoyment of nearby residents of their property. (D) Licensees shall abide by all other requirements adopted through regulation by the regulatory authorities. (3) Follow all regulations adopted by the regulatory authorities in order to implement and enforce this chapter. (b) All licensees may test medical cannabis or medical cannabis products for the purposes of conducting quality assurance testing. Tests completed by licensees without a testing license shall not substitute tests required for commercial cannabis activity under this chapter. Any licensees found to be substituting tests required under this chapter with unauthorized tests shall be fined and be under review for the revocation of licensure by the appropriate regulatory authority. 26042. Each regulatory authority shall establish appropriate fees as part of its emergency regulations for the issuance of provisional licenses adopted pursuant to Section 26043. 26043. Each regulatory authority shall adopt, as soon as practicable, emergency regulations consistent with this chapter to allow a qualified applicant for licensure to apply for and receive a provisional license to engage in commercial cannabis activity so as to ensure an adequate supply of medical cannabis upon full implementation of this chapter as set forth in Section 26054. 26044. Every mandatory commercial license is renewable unless the license has been revoked if the renewal application is submitted and the fee for it is paid. A license that has been suspended, but not revoked, may be renewed under this section, however, the act of renewal shall not affect the suspension and the suspension shall remain in effect upon renewal. All licenses expire at 12 midnight on the last day of the month posted on the license. All licenses shall be renewed as follows: (a) The application to renew the license may be filed before the license expires upon payment of the annual fee. (b) For 60 days after the license expires, the license may be renewed upon payment of the annual renewal fee plus a penalty fee that shall be equal to 50 percent of the annual fee. (c) Unless otherwise terminated, or unless renewed pursuant to subdivision (a) or (b), a license that is in effect on the month posted on the license continues in effect through 12 midnight of the 60th day following the month posted on the license, at which time it is automatically canceled. (d) A license that has been canceled pursuant to subdivision (c) may be reinstated during the 30 days immediately following cancellation upon payment by cashier's check or money order of the annual renewal fee, plus a penalty fee that shall be equal to 100 percent of the annual fee. A license that has been canceled pursuant to subdivision (c) and that has not been reinstated within 30 days pursuant to this subdivision is automatically revoked on the 31st day after the license has been canceled. (e) A renewal application shall not be deemed filed within the meaning of this section unless the document itself has been actually delivered to, and the required renewal fee has been paid at, any office of the division during office hours, or unless both the document and fee have been filed and remitted pursuant to Section 11003 of the Government Code. 26045. A person may engage in commercial cannabis activity only if the person has complied with all of the following conditions: (a)The(1) Except as provided in paragraph (2), the person has obtained permission from local authorities approving the proposed commercial cannabis activity.This requirement shall not apply to a person who holds a valid business license, conditional use permit, or other locally issued permit for commercial cannabis activity.For the purposes of this subdivision, the document granting the permission shall be issued by the local authority and include, at a minimum, all of the following:(1)(A) The legal name,addressaddress, and date of birth of the applicant.(2)(B) The type of license the applicant is requesting a permit for.(3)(C) Documentation that the applicant has been in compliance with local ordinances and regulations, including, but not limited to, an entity granted immunity under Measure D, approved by the voters of the City of Los Angeles at the May 21, 2013, general election.(4)(D) A statement of whether or not the applicant has previously committed a felony, as described in paragraph (8) of subdivision (e) of Section 26047.(5)(E) A statement signed by the applicant under penalty of perjury that the information provided in the application is true. (2) Paragraph (1) shall not apply to a person who holds a valid business license, conditional use permit, or other locally issued permit for commercial cannabis activity. Those persons who are applying for licensure in a jurisdiction covered by Measure D, approved by the voters of the City of Los Angeles at the May 21, 2013, general election, in lieu of the requirement in paragraph (1), shall provide documentation that the applicant has been in compliance with the terms of granted immunity under that measure. (b) The person submits a copy of the permission, or equivalent qualifying documents, to the division for recordation. Upon receipt of an approved permission, the division shall provide the applicant with a certificate of approval for licensure, to be presented to the relevant regulatory authority under which the person seeks licensure. No regulatory authority shall grant approval of an application without a certificate of approval for application of commercial cannabis licensure for the applicant. (c) The person applies for licensure for commercial cannabis activity from a regulatory authority and receives approval for that licensure. (d) The person abides by all local and state ordinances and regulations pursuant to this chapter. 26046. (a) An application for a license shall include, but shall not be limited to, all of the following: (1) A certificate of approval for licensure by the Division of Medical Cannabis Regulation and Enforcement. (2) The legal name and proposed physical addresses of the mandatory commercial licensee. (3) The name, address, and date of birth of each principal officer and board member. (4) Operating and inventory control procedures to ensure security and prevent diversion. (5) Detailed operating procedures for the proposed facility, which shall include, but not be limited to, provisions for facility and operational security, prevention of diversion, employee screening, storage of medical cannabis, personnel policies, and recordkeeping procedures. (6) A list of all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on any property that will be used by the applicant. (7) Evidence of the legal right to occupy and use an established location, including that if the proposed facility is a cultivator or a dispensary, that the proposed facility is located beyond at least a 600-foot radius from a school, or an immunity from prosecution for that occupancy or use pursuant toa local ordinance or ordinances, including, but not limited to,Measure D, approved by the voters of the City of Los Angeles at the May 21, 2013, general election. (8) Documentation that the applicant will be in compliance with all local ordinances and regulations, including, but not limited to, an entity granted immunity under Measure D, approved by the voters of the City of Los Angeles at the May 21, 2013, general election. (9) Evidence that all of the officers and owners of the applicant organization have been residents of the State of California for at leastthree years.the three years prior to the date of applying for licensure. (10) (A) For an applicant with 20 employees or more, a statement that the applicant will enter into, or demonstrate that it has already entered into, and abide by the terms of, a"labor peace agreement," as defined by the division in consultation with the Division of Labor Standards Enforcement.labor peace agreement. (B) For the purposes of this paragraph, "employee" does not include any employee who is a supervisor, defined as any individual having authority, in the interest of the licensee, to hire, transfer, suspend, lay off, recall, promote, discharge, assign, reward, or discipline other employees, or responsibility to direct them or to adjust their grievances, or effectively to recommend such action, if in connection with the foregoing the exercise of such authority is not of a merely routine or clerical nature, but requires the use of independent judgment. (11) For an applicant seeking a license to cultivate, a statement declaring the applicant is an "agricultural employer," as defined in the Alatorre-Zenovich-Dunlap-Berman Agricultural Labor Relations Act of 1975 (Part 3.5 (commencing with Section 1140) of Division 2 of the Labor Code), to the extent not prohibited by law. (12) A statement signed by the applicant under penalty of perjury that the information provided in the application is true. (13) For an applicant seeking a cultivation or dispensary license, a notarized statement from the owner of real property or landlord where the cultivation or dispensing commercial cannabis activities will occur, as proof to demonstrate the landowner has acknowledged and consented to permit cultivation or dispensary activities to be conducted on the property by the tenant applicant. (b) For applicants seeking a license to cultivate and manufacture, the application shall also include a detailed description of the operating procedures for all of the following: (1) Cultivation. (2) Extraction and infusion methods. (3) The transportation process. (4) Inventory procedures. (5) Quality control procedures. 26047. (a) Upon receipt of an application for licensure and the applicable fee, the respective regulatory authority shall make a thorough investigation to determine whether the applicant and the premises for which a license is applied qualify for the license and whether this chapter has been complied with, and shall investigate all matters connected therewith that may affect the public welfare and morals. (b) The respective regulatory authority shall deny an application if either the applicant or the premises for which a license is applied do not qualify for licensure under this chapter. (c) The respective regulatory authority may place reasonable conditions upon licensure if grounds exist for denial of the license, and the division finds those grounds may be removed by the imposition of those conditions. However, the limitations set forth in paragraph (10) of subdivision (d) shall not be waived. (d) The respective regulatory authority shall deny the application for licensure or renewal, or suspend or revoke a license, if any of the following conditions apply: (1) Granting or continuation of a license would be contrary to the public welfare or morals. (2) The applicant holding or seeking a license has violated any law prohibiting conduct involving moral turpitude. (3) Local agencies have notified the division and provided evidence that a licensee or applicant within its jurisdiction is in violation of local ordinances relating to cannabis activities. (4) The application has failed to state with sufficient specificity the jurisdictioninand location at which the applicant proposes to establish operations. (5) The applicant fails to meet the requirements of this chapter or any regulation adopted pursuant to this chapter, or any applicable city or county ordinance or regulation. (6) The applicant, or any of its officers, directors, or owners, is under 21 years of age. (7) The applicant fails to provide notarized written proof that the owner of real property or landlord has acknowledged and consented to its tenant's proposed cultivation or dispensing of medical cannabis or medical cannabis products.(7)(8) The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.(8)(9) The applicant, or any of its officers, directors, or owners has been convicted of a felony criminal conviction for drugtrafficking,trafficking involving a minor, felonies subject to enhancements Section 13370.4 or 11379.8 of the Health and Safety Code, a violent felony, as specified in subdivision (c) of Section 667.5 of the Penal Code, a serious felony as specified in subdivision (c) of Section 1192.7 of the Penal Code, a felony offense involving fraud or deceit, or any other felony that, in the division's determination, would impair the applicant's ability to appropriately operate as a mandatory commercial licensee. The respective regulatory authority may, at its discretion, issue a license to an applicant that has obtained a certificate of rehabilitation pursuant to Section 4852.13 of the Penal Code.(9)(10) The applicant, or any of its officers, directors, or owners is a licensed physician making patient recommendations for medical cannabis.(10)(11) The applicant, or any of its officers, directors, or owners has been sanctioned by a regulatory authority, a city, or a county for unlicensed commercial medical cannabis activities or has had a license revoked under this chapter in the previous three years. (12) The applicant, or any of its officers, directors, or owners, has been subject to fines or penalty for cultivation or production of a controlled substance on public or private lands pursuant to Section 12025 of the Fish and Game Code. (13) The proposed commercial cannabis activity will violate any applicable local law or ordinance. (14) The applicant has had 20 employees or more in the past year and failed to enter into a labor peace agreement.(11)(e) Applicants shall be notified of a denied application in writing via personal service or mail addressed to the address of the applicant or licensee set forth in the application. The denial letter shall contain the detailed reasons for which the application has been denied. The applicant shall have the right to appeal the denial and be given a hearing within 30 days of the appeal. On appeal, the decision shall be upheld unless the applicant demonstrates that the applicant is in fact eligible for licensure and the application is in compliance with this chapter. 26048. (a) The respective regulatory authority shall electronically submit to the Department of Justice fingerprint images and related information for all applicants for cultivation, dispensing, manufacturing, and transportation licenses for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information regarding whether the person is free on bail, or on his or her own recognizance, pending trial or appeal. (b) The Department of Justice shall provide a response to the division pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code. (c) The division shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in this section. (d) The Department of Justice shall charge a fee sufficient to cover the reasonable cost of processing the requests described in this section. 26049. (a) The actions of a mandatory commercial licensee or provisional licensee, its employees, and its agents, permitted pursuant to a mandatory commercial license or provisional license issued by thedivision or otherwise permitted by this chapter,regulatory authority that are within the scope of the license issued pursuant to this chapter and the regulations adopted pursuant to the authority granted by this chapter, are not unlawful under statelawlaw, and shall not be an offense subject to arrest, prosecution, or other sanction under state law, or be subject to a civil fine or be a basis for seizure or forfeiture of assets under state law. (b) The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a mandatory commercial licensee or provisional licensee, its employees, and its agents, as permitted pursuant to a mandatory commercial license or provisional license issued by the division or otherwise permitted by this chapter, are not unlawful under state law and shall not be an offense subject to arrest, prosecution, or other sanction under state law, or be subject to a civil fine or be a basis for seizure or forfeiture of assets under state law. (c) Conduct that is within the scope of a license issued pursuant to this chapter and permitted by local ordinance but not fully in compliance with this chapter shall be subject to the enforcement provisions of this chapter and shall not be subject to the penal provisions of state law generally prohibiting cannabis-related activity, unless and until the license is revoked. (d) This section shall not be deemed to limit the authority or remedies of a city or county under any provision of law, including, without limitation, Section 7 of Article XI of the California Constitution or Section 26010 or 26060. 26050. (a) A licensee shall keep, at the licensed premises, accurate records of the specific commercial cannabis activity conducted by the licensee. The records shall include, at a minimum, all of the following for each batch of product: (1) The name and address of the supplier. (2) The dates on which the product was received. (3) The amounts, form, and batch and lot number. (4) The location of the cultivation site. (5) The name of the employee who received the product. (6) Records demonstrating compliance by the licensee with state and federal rules and regulations regarding reporting and taxation of income received. (7) Receipts for all expenditures incurred by the registrant and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the registration. (b) The records shall be kept for a minimum of seven years. (c)The divisionRegulatory authorities and any relevant local agency may make any examination of the books and records of any licensee and may visit and inspect the premises of any licensee that thedivisionregulatory authority or local agency may deem necessary to performitstheir duties under thischapter.chapter or local ordinance. (d) If the licensee or any employee of the licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to this chapter or local ordinance, or if the licensee fails to maintain or provide the books and records required by this section, the license may be summarily suspended and the division shall directly commence proceedings for the revocation of the license in accordance with this chapter. (e) All cultivation, dispensing, and retail sales licensees shall be subject to an annual audit, as specified by the regulatory authority, in order to ensure proper documentation is kept at each site or facility. The reasonable costs of the audit shall be paid for by the licensee. 26052. (a) This chapter shall not apply to, and shall have no diminishing effect on, therights andprotections granted to a patient or a primary caregiver pursuant to the Compassionate Use Act of 1996. (b) (1) A patient who cultivates, possesses, stores, manufactures, or transports cannabis exclusively for his or her personal medical use but who does notsell orprovide, donate, sell, or distribute cannabis to any other person is not, thereby, engaged in commercial cannabis activity and is, therefore, exempt from the licensure requirements of this chapter. (2) A primary caregiver who cultivates, possesses, stores, manufactures, transports, donates, or provides cannabis exclusively for the personal medical purposes ofano more than five specified qualified patient for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code but who does not receive remuneration for these activities except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code is not, thereby, engaged in commercial cannabis activity and is, therefore, exempt from the licensure requirements of this chapter. (c) Exemption from the license requirements of this part shall not limit or prevent a city, county, or city and county from regulating or banning the cultivation, storage, manufacture, transport, provision, or other activity by the exempt person, or impair the enforcement of that regulation or ban. 26054. (a) Each regulatory authority shall, as soon as practicable following January 1, 2016, allow a qualified applicant for licensure to apply for and receive a provisional license to engage in commercial cannabis activity so as to ensure an adequate supply of medical cannabis upon full implementation of this chapter. (b) Each regulatory authority shall establish appropriate fees not to exceed the reasonable regulatory costs to the regulatory authority for the issuance of a provisional license under its jurisdiction pursuant to this chapter. (c) Each regulatory authority shall, if the applicant meets all the requirements in this section, issue a provisional license to individuals and entities that the regulatory authority determines were, during the3three months prior to January 1, 2016, regularly cultivating, processing, manufacturing, transporting, or distributing medical cannabis collectively or cooperatively in full compliance with any applicable local ordinance, to continue to do so until the licensee's application for mandatory commercial licensure has been approved or denied under this chapter, but no later than 90 days after the regulatory authority begins accepting applications for regular mandatory commercial licenses. The regulatory authority may consult with relevant local agencies in making a determination on whether a provisional license applicant is in compliance with any applicable ordinance. (d) To qualify for a provisional mandatory commercial license, applicants shall disclose to the appropriate regulatory authority all of the following information in writing: (1) The names, addresses, and dates of birth of each principal officer, owner, or board member. (2) The common street address and assessor's parcel number of the property at which the licensee conducts any activity under the authority of the licensee. (3) The common street address and assessor's parcel number of the property at which any cultivation activity was or is to be conducted. (4) For the3three months prior to January 1, 2016, the quantity of cannabis cultivated, processed, manufactured, tested, transported, or sold at a location and the quantity expected to be cultivated, processed, manufactured, tested, transported, or sold from January 1, 2016, to July 1, 2016, inclusive. The licensee shall make its records of current activity and activity for the3three months prior to January 1, 2016, available to the division upon request. (5) For an applicant seeking a cultivation or dispensary license, a notarized statement from the owner of real property or landlord where the cultivation or dispensing commercial cannabis activities will occur, as proof to demonstrate the landowner has acknowledged and consented to permit cultivation or dispensary activities to be conducted on the property by the tenant applicant. (e) Upon receipt of the application materials and fee, the division shall issue a provisional license and send a proof of issuance to the applicant that meets all the requirements of this section, if the applicant has not committed any act or crime constituting grounds for the denial of licensure. (f) Notwithstanding any other provision of this section, the division shall not issue a provisional license to an individual or entity, or for a premises, against whom there are pending state or local administrative or judicial proceedings or actions initiated by a city, county, or city and county under any applicable local ordinance or who has been determined through those proceedings to have violated any local ordinance related to cannabis activity, or that knowingly provides false or fraudulent information on an application for licensure. (g) Entities that are provided immunity under Measure D, approved by the voters of the City of Los Angeles at the May 21, 2013, general election, shall be considered the equivalent of entities that are registered, permitted, or licensed as a medical marijuana business, dispensary, or other entity involved in providing medical marijuana to patients under a local ordinance and shall be considered in compliance with a local ordinance for the purposes of the implementation of this section. (h) Provisional licensees shall comply with all standards and requirements applicable to a licensee under this chapter, including, but not limited to, the production, recordkeeping, security, and transportation requirements and standards. (i) Beginning July 1, 2017, all commercial cannabis activity shall be conducted between licensees of commercial cannabis activity, pursuant to this chapter. If the regulatory authorities have not promulgated their respective regulations by that date, the regulatory authorities shall provide an extension for all provisional licenses for applicants abiding by the provisions of this chapter. 26055. The regulatory authority may adopt regulations to permit the transfer of a license from a licensee to another person who demonstrates to the regulatory authority that he or she is eligible for licensure under this chapter, if the prospective recipient of the license complies with all of the requirements of this chapter relating to a new application for licensure, including, but not limited to, payment to the regulatory authority of a reasonable license transfer fee. 26057. Each regulatory authority shall make recommendations to the Legislature pertaining to the establishment of an appeals and judicial review process for persons aggrieved by a final decision of the regulatory authority. Article 4. Enforcement 26060. (a) Each regulatory authority shall work in conjunction with law enforcement agencies for the purposes of implementing, administering, and enforcing this chapter and any regulations adopted pursuant to this chapter and taking appropriate action against licensees and others who fail to comply with this chapter or the regulations adopted pursuant to this chapter. (b) Nothing in this chapter or in Article 2 (commencing with Section 11357) or Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code, shall prevent a city, county, or city and county from adopting or enforcing a zoning ordinance or other law, ordinance, or regulation that bans or regulates the location, operation, or establishment of a licensee or other person that engages in commercial cannabis activity. 26062. Except for a person identified in Section 26052, a person shall not exercise the privilege or perform any act that a licensee may exercise or perform under the authority of a license unless the person is acting pursuant to a license, including, but not limited to, a provisional license issued pursuant to this chapter. 26064. Any person engaging in commercial cannabis activity and operating an unlicensed facility, building, structure, vehicle, mobile unit, or location in violation of this chapter shall be subject to civil penalties of up to twice the amount of the license fee for each violation, and the division or court may order the destruction of any cannabis associated with that violation. Each day of operation shall constitute a separate violation of this section. All civil fines imposed and collected pursuant to this section shall be deposited into the fines and penalties account established pursuant to Section 26028. If an action for civil penalties is brought by the Attorney General, the penalty collected shall be deposited into the General Fund pursuant to Section 26028. If the action is brought by a district attorney or county counsel, the penalty collected shall be paid to the treasurer of the county in which the judgment was entered. If the action is brought by a city attorney or city prosecutor, the penalty collected shall be paid to the treasurer of the city in which the judgment was entered. 26066. (a) Any regulatory director or any district attorney, county counsel, city attorney, or city prosecutor may bring an action in the name of the people of the State of California to enjoin a violation or the threatened violation of any provision of this chapter, including, but not limited to, a licensee's failure to correct objectionable conditions following notice or as a result of any rule promulgated pursuant to this chapter, and to assess and recover civil penalties in accordance with this chapter. The action shall be brought in the county in which the violation occurred or is threatened to occur. Any proceeding for injunctive relief brought pursuant to this chapter shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. (b) A state or local agency shall immediately notify the division and the appropriate regulatory authority of any violations or arrests made for violations over which the division or regulatory authority has jurisdiction which involve a licensee or licensed premises. Notice shall be given within 10 days of the violation or arrest. The division or regulatory authority shall promptly cause an investigation to be made as to whether grounds exist for suspension or revocation of the license. (c) This chapter shall not be construed to limit a law enforcement agency's ability to investigate unlawful activity in relation to a mandatory commercial licensee. (d) The division shall keep a complete record of all entities licensed pursuant to this chapter. This record shall be made available to state and local law enforcement to verify a mandatory commercial license. (e) A city, county, or city and county may impose a temporary local suspension of the license of a commercial licensee for up to 30 days for violations of this chapter or a local ordinance. The regulatory authority shall promptly cause an investigation to be made as to whether grounds exist for continued suspension or revocation of the license. If the regulatory authority has not completed its investigation or disciplinary action within 30 days, a city, county, or city and county may impose a subsequent temporary local suspension of the license of a commercial licensee for the same violation until the regulatory authority's investigation, the suspension or revocation, and all appeals to that suspension or revocation are complete. This subdivision shall not limit a city's, county's, or city and county's authority to enforce laws or ordinances pursuant to the authority granted by Section 7 of Article XI of the California Constitution. Article 5. Transportation of Medical Cannabis 26100. A licensee authorized totransporttransport, or transport and deliver, medical cannabis and medical cannabis products shall do so only as set forth in this chapter. 26102. (a) Prior to transporting or delivering medical cannabis or medical cannabis products, a licensee authorized to transport or deliver, medical cannabis or medical cannabis products shall do both of the following: (1) Complete an electronic shipping manifest as prescribed by the division. All delivery shipping manifests shall not identify the qualified patient or primary caregiver by name or address. (2) Securely transmit the manifest to the division and the licensee that will receive the medical cannabisproduct.product, as applicable. (b) Duringtransportation,transportation or delivery, the licensed transporter shall maintain a physical copy of the shipping manifest and make it available upon request to agents of the division, local law enforcement officers, or any other designated enforcement agency. (c) The licensee receiving the shipment shall maintain each electronic shipping manifest and shall make it available upon request to agents of the division, local law enforcement officers, or any other designated enforcement agency. (d) Upon receipt of the transported shipment, a licensed facility shall submit to the division a record verifying receipt of the shipment and the details of the shipment. 26104. (a) Transported and delivered medical cannabis or medical cannabis products shall be transported only in a storage compartment that is securely affixed to the interior of the transporting vehicle, and shall not be visible from outside the vehicle. This requirement shall only apply to licensees transporting medical cannabis or medical cannabis products with a total retail value ofover five hundred dollars ($500).at least an amount equal to a statewide monetary threshold, which shall be adopted by regulation by the regulatory authorities after review by the task force and regulatory authorities. (b) A vehicle transporting medical cannabis or medical cannabis products shall travel only directly between licensed facilities, unless otherwise authorized under its license. (c) All transport or delivery vehicles shall be staffed with a minimum of two employees. At least one transport member shall remain with the vehicle at all times when the vehicle contains medical cannabis. This requirement shall only apply to licensees transporting medical cannabis or medical cannabis products with a total retail value ofover five thousand dollars ($5,000).at least an amount equal to a statewide monetary threshold, which shall be adopted by regulation by the regulatory authorities after review by the task force and regulatory authorities. (d) Each transport or delivery team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical cannabis and shall produce it upon the request of agents of any regulatory authority or any law enforcement officials. 26105. (a) The division shall develop a database containing the electronic shipping manifests, which shall include, but are not limited to, the following information: (1) The quantity, or weight, and variety of products shipped. (2) The estimated times of departure and arrival. (3) The quantity or weight, and variety of products received. (4) The actual time of arrival. (5) A categorization of the product. (b) The database shall be designed to flag irregularities for any regulatory authority to investigate. Any regulatory authority may, at any time, inspect shipments and request documentation for current inventory. 26106. (a) This chapter shall not be construed to authorize or permit any licensee to transport or deliver, or cause to be transported or delivered, cannabis or cannabis products outside the state, unless authorized by federal law. (b) A local jurisdiction shall not prevent transportation of medical cannabis or medical cannabis products on public roads by a licensee transporting medical cannabis or medical cannabis products that acts in compliance with this chapter. (c) A local jurisdiction shall not prevent delivery of medical cannabis or medical cannabis products on public roads by a licensee delivering medical cannabis or medical cannabis products that acts in compliance with this chapter and eligible local ordinances. 26107. (a) All mobile, vehicular, and Internet-based-delivery services are prohibited except as authorized by this chapter. (b) Upon approval of the division, a licensee registered to provide delivery services, shall abide by the following conditions of the license: (1) The city or county in which the licensed premises of the licensee are located, and in which each delivery is made must specifically permit delivery service by ordinance referring to this section. (2) Transportation of medical cannabis or medical cannabis products for delivery under this section shall comply with subdivisions (b) and (c) of Section 26102 and subdivisions (a), (c), and (d) of Section 26104. (3) All employees delivering medical cannabis or medical cannabis products must carry a current license authorizing those services with them during deliveries, and must present them upon request to state and local law enforcement, employees of regulatory authorities, and other state and local agencies enforcing this chapter. (c) Cities and counties shall have the authority to impose a tax, pursuant to Section 23028 of the Government Code, on each delivery transaction completed by an authorized licensee. (d) Whenever a regulatory authority has knowledge that a licensed facility has transported or delivered, or arranged or facilitates the transport or delivery of, medical cannabis or medical cannabis products in violation of this chapter, the regulatory authority shall summarily suspend the license of that facility and shall without delay commence proceedings for the revocation of the license in accordance with this part. Article 6. Cannabis Employee Certification and Apprenticeship Program for Cultivation Sites and Dispensaries 26140. This article applies only to cultivation sites and dispensaries. 26140.5. The Division of Labor Standards Enforcement shall do all of the following: (a) Maintain minimum standards for the competency and training of employees of a licensed cultivator or dispensary through a system of testing and certification. (b) Maintain an advisory committee and panels as necessary to carry out its functions under this article. There shall be employer representation on the committee and panels. (c) Adopt regulations as determined to be necessary to implement this article. (d) Issue certification cards to employees certified pursuant to this article. (e) Establish registration fees in an amount reasonably necessary to implement this article, not to exceed twenty-five dollars ($25) for the initial registration. There shall be no fee for annual renewal of registration.Fees shall be placed in the fund.Fees collected for cultivation sites and dispensaries shall be placed into the Medical Cannabis Cultivation Fee Account and the Medical Cannabis Retail Fee Account, respectively. 26141. (a) By January 1, 2017, the Division of Labor Standards Enforcement shall develop a certification program for cannabis employees. Commencing January 1, 2019, except as provided in subdivision (c), certification shall be required of all persons who perform work as cannabis employees. (b) Individuals desiring to be certified shall submit an application for certification and examination. (c) (1) Certification is not required for registered apprentices working as cannabis employees as part of a state-approved apprenticeship program. An apprentice who is within one year of completion of his or her term of apprenticeship shall be permitted to take the certification examination and, upon passing the examination, shall be certified immediately upon completion of the term of apprenticeship. (2) Commencing January 1, 2019, an uncertified person may perform work for which certification is otherwise required in order to acquire the necessary on-the-job experience for certification provided that the person shall be under the direct supervision of a cannabis employee certified pursuant to Section 26141 who is responsible for supervising no more than one uncertified person. (3) The Division of Labor Standards Enforcement may develop additional criteria governing this subdivision. 26141.5. (a) The following shall constitute additional grounds for disciplinary proceedings, including suspension or revocation of the license issued pursuant to this chapter: (1) The licensee willfully employs one or more uncertified persons to perform work as cannabis employees in violation of this section. (2) The licensee willfully fails to provide adequate supervision of uncertified workers. (3) The licensee willfully fails to provide adequate supervision of apprentices performing work pursuant to paragraph (1) of subdivision (c) of Section 26141. (b) The Labor Commissioner shall maintain a process for referring cases to the appropriate regulatory authority when it has been determined that a violation of this section has likely occurred. The Labor Commissioner shall have a memorandum of understanding with the regulatory authorities in furtherance of this section. (c) Upon receipt of a referral by the Labor Commissioner alleging a violation under this section, the appropriate regulatory authority shall open an investigation. Disciplinary action against the licensee shall be initiated within 60 days of the receipt of the referral. The regulatory authority may initiate disciplinary action against a licensee upon his or her own investigation, the filing of a complaint, or a finding that results from a referral from the Labor Commissioner alleging a violation under this section. Failure of the employer or employee to provide evidence of certification or apprentice status shall create a rebuttable presumption of violation of this provision. (d) This section shall become operative on January 1, 2019. SEC. 6. Section 23028 is added to the Government Code, to read: 23028. (a) (1) In addition to any authority otherwise provided by law, the board of supervisors of anycountycounty, and the city council of any city, may impose, by ordinance, a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing cannabis by a licensee operating pursuant to the Medical Cannabis Regulation and Control Act (Chapter 18 (commencing with Section 26000) of Division 9 of the Business and Professions Code). The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors. (2) The board of supervisors or city council shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, and the manner of collection of the tax. A tax imposed pursuant to this section is a tax and not a fee or special assessment, and the tax is not required to be apportioned on the basis of benefit to any person or property or be applied uniformly to all taxpayers or all real property. (3) A tax imposed by a county or city pursuant to this sectionby a countymay include a transactions and use tax imposed solely for medical cannabis or medical cannabis products, which shall otherwise conform to Part 1.6 (commencing with Section 7251) of Division 2 of the Revenue and Taxation Code. Notwithstanding Section 7251.1 of the Revenue and Taxation Code, the tax may be imposed at any rate specified by the board ofsupervisors,supervisors or city council, and the tax rate authorized by this section shall not be considered for purposes of the combined tax rate limitation established by that section. (4) The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1), regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors. (5) The board of supervisors or city council shall specify whether the tax applies throughout the entire county or city, or within the unincorporated area of the city or county. (b) In addition to any other method of collection authorized by law, the board of supervisors or city council may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the city or county. (c) Any tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by any other law. (d) For purposes of this section, "marijuana" or "cannabis" shall have the meanings set forth in Section 26002 of the Business and Professions Code. (e) This section is declaratory of existing law and does not limit or prohibit the levy or collection or any other fee, charge, or tax, or any license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of any county as provided by other law.(f) The total taxation of state and local authorities shall not be in excess of 25 percent of retail prices.SEC. 7. Section 11362.775 of the Health and Safety Code is amended to read: 11362.775. (a) Subject to subdivision (b), qualified persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who associate within the State of California in order to collectively or cooperativelytocultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570. (b) Commencing 180 days following the issuance of provisional licenses pursuant to the Medical Cannabis Regulation and Control Act (Chapter 18 (commencing with Section 26000) of Division 9 of the Business and Professions Code), subdivision (a) shall not apply to licensees under that act or to any persons who collectively orcooperativecooperatively cultivate marijuana for medical purposes. Each regulatory authority shall post a notice on its Internet Web site indicating when it has commenced issuing provisional licenses and when the 180-day period has been exhausted. SEC. 8. Section 147.5 is added to the Labor Code, to read: 147.5. (a) By January 1, 2017, the Division of Occupational Safety and Health shall convene an advisory committee to evaluate whether there is a need to develop industry-specific regulations related to the activities of facilities issued a license pursuant to Chapter 18 (commencing with Section 26000) of Division 9 of the Business and Professions Code. (b) By July 1, 2017, the advisory committee shall present to the board its findings and recommendations for consideration by the board. By July 1, 2017, the board shall render a decision regarding the adoption of industry-specific regulations pursuant to this section. SEC. 9. Section 3094 is added to the Labor Code, to read: 3094. The Division of Apprenticeship Standards shall investigate, approve, or reject applications for apprenticeship programs for employees of a licensee subject to Article 6 (commencing with Section 26140) of Chapter 18 of Division 9 of the Business and Professions Code. The Division of Apprenticeship Standards shall adopt regulations necessary to implement and regulate the establishment of the apprenticeship programs described in this section. SEC. 10. The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application. SEC. 11. The Legislature finds and declares that Section 5 of this act, which adds Chapter 18 (commencing with Section 26000) to Division 9 of the Business and Professions Code, imposes a limitation on the public's right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest: It is necessary to maintain the confidentiality of patient and physician information provided to the regulatory authorities in order to protect the private medical information of patients who use medical cannabis and to preserve the essential confidentiality of the physician and patient relationship. SEC. 12. No reimbursement is required by this act pursuant to Section 6 of Article XIII B of the California Constitution for certain costs that may be incurred by a local agency or school district because, in that regard, this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIII B of the California Constitution. However, if the Commission on State Mandates determines that this act contains other costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.